Literature DB >> 11445891

Toxicokinetics of inhaled benzo[a]pyrene: plasma and lung bioavailability.

A Ramesh1, M Greenwood, F Inyang, D B Hood.   

Abstract

Bioavailability and toxicokinetic studies are essential in order to establish dose-response relationships of widely distributed environmental toxicants such as benzo[a]pyrene (BaP), a polycyclic aromatic hydrocarbon. Fischer 344 rats were exposed for 4 h (via nose-only inhalation) to aerosol exposure concentrations of 0.1, 1.0, and 2.5 mg/m(3) of BaP absorbed onto carbon black particles using a state-of-the-art model aerosol generation system. Nominal and chamber concentrations of the particulate aerosol were determined gravimetrically with a seven-stage cascade impactor. The average aerosol for the 3 exposure concentrations used in this study exhibited a trimodal distribution with 93% cumulative mass less than 15.85 microm, 89% cumulative mass less than 10 microm, 55.3% cumulative mass less than 2.5 microm, and 38% less than 1 microm. Fifty-five percent of the aerosol had a cumulative mass less than PM(2.5) and the mass median aerodynamic diameter (MMAD) -/+ geometric standard deviation (GSD) for this mode was 1.7 -/+ 0.085 microm. Plasma and lung samples were collected at 30, 60, 120, and 240 min postexposure. The concentrations of BaP parent compound and metabolites were determined by high-performance liquid chromatography. The toxicokinetic parameters were computed from the time course of plasma BaP concentration. The bioavailability of BaP increased as a function of exposure concentration, and toxicokinetic analysis indicates first-order pharmacokinetics for BaP. However, some toxicokinetic parameters such as clearance and volume of distribution remained constant throughout the duration of the postexposure period. BaP and its metabolite concentrations in plasma peaked at 1 h postexposure. At 240 min postexposure, only trace levels of BaP remained in the plasma. The BaP metabolites in the lung showed an identical trend where no parent compound was detected. Among the metabolites detected, BaP 4,5-, 7,8-, and 9,10-dihydrodiols, 3-OH-BaP, and 9-OH-BaP were predominant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445891     DOI: 10.1080/08958370118859

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  5 in total

1.  Endocrine disruptive actions of inhaled benzo(a)pyrene on ovarian function and fetal survival in fisher F-344 adult rats.

Authors:  Anthony E Archibong; Aramandla Ramesh; Frank Inyang; Mohammad S Niaz; Darryl B Hood; Prapaporn Kopsombut
Journal:  Reprod Toxicol       Date:  2012-10-08       Impact factor: 3.143

2. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-08       Impact factor: 1.513

3.  Mixture Analysis of Associations between Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Sperm Oxidative DNA Damage.

Authors:  Hueiwang Anna Jeng; Sinjini Sikdar; Chih-Hong Pan; Guo-Ping Chang-Chien
Journal:  Ann Work Expo Health       Date:  2022-02-18       Impact factor: 2.779

4.  Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats.

Authors:  Roberto Heredia-Ortiz; Michèle Bouchard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-10-29       Impact factor: 2.745

5.  Predicting lung dosimetry of inhaled particleborne benzo[a]pyrene using physiologically based pharmacokinetic modeling.

Authors:  Jerry Campbell; Allison Franzen; Cynthia Van Landingham; Michael Lumpkin; Susan Crowell; Clive Meredith; Anne Loccisano; Robinan Gentry; Harvey Clewell
Journal:  Inhal Toxicol       Date:  2016-09       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.